103 related articles for article (PubMed ID: 18689862)
21. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
22. DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 cases.
Agaram NP; Shia J; Tang LH; Klimstra DS
Am J Clin Pathol; 2010 May; 133(5):772-80. PubMed ID: 20395525
[TBL] [Abstract][Full Text] [Related]
23. Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia.
Chen MC; Chen YL; Wang TW; Hsu HP; Lai MD
Oncol Rep; 2016 Oct; 36(4):1997-2008. PubMed ID: 27510297
[TBL] [Abstract][Full Text] [Related]
24. Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer.
Santini D; Perrone G; Vincenzi B; Lai R; Cass C; Alloni R; Rabitti C; Antinori A; Vecchio F; Morini S; Magistrelli P; Coppola R; Mackey JR; Tonini G
Ann Oncol; 2008 Apr; 19(4):724-8. PubMed ID: 18187485
[TBL] [Abstract][Full Text] [Related]
25. Expression of MUC1 and MUC2 in ampullary cancer.
Moriya T; Kimura W; Hirai I; Takasu N; Mizutani M
Int J Surg Pathol; 2011 Aug; 19(4):441-7. PubMed ID: 21700631
[TBL] [Abstract][Full Text] [Related]
26. Expression of thymidylate synthase in cancer of the ampulla of Vater.
Ajiki T; Habara K; Kamigaki T; Nakamura T; Fujino Y; Suzuki Y; Takeyama Y; Kuroda Y; Nakamura T
Oncol Rep; 2001; 8(4):759-62. PubMed ID: 11410778
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma.
Santini D; Vincenzi B; Perrone G; Rabitti C; Borzomati D; Valeri S; Coppola R; Magistrelli P; Tonini G
Ann Oncol; 2005 Nov; 16(11):1847-8. PubMed ID: 15972277
[No Abstract] [Full Text] [Related]
28. PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapy.
Vincenzi B; Santini D; Schiavon G; Frezza AM; Silletta M; Crucitti P; Casali P; Dei Tos AP; Rossi S; Rizzo S; Badalamenti G; Tomasino RM; Russo A; Butrynski JE; Tonini G
J Cell Physiol; 2012 Apr; 227(4):1657-62. PubMed ID: 21678421
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.
Qiao QL; Zhao YG; Ye ML; Yang YM; Zhao JX; Huang YT; Wan YL
World J Surg; 2007 Jan; 31(1):137-43; discussion 144-6. PubMed ID: 17171495
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic significance of livin, caspase-3, and ki-67 in the progression of human ampullary carcinoma.
Xue D; Zuo K; Li X; Zhang T; Chen H; Cheng Y; Chen Y
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):525-31. PubMed ID: 23343959
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
32. The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.
Chen SC; Shyr YM; Chou SC; Wang SE
World J Surg Oncol; 2015 Jul; 13():224. PubMed ID: 26205252
[TBL] [Abstract][Full Text] [Related]
33. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
34. Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance.
Liu F; Shen D; Ma Y; Song Q; Wang H
J Surg Oncol; 2019 Mar; 119(3):295-302. PubMed ID: 30548547
[TBL] [Abstract][Full Text] [Related]
35. Promyelocytic leukemia protein enhances apoptosis of gastric cancer cells through Yes-associated protein.
Xu Z; Chen J; Shao L; Ma W; Xu D
Tumour Biol; 2015 Sep; 36(10):8047-54. PubMed ID: 25971581
[TBL] [Abstract][Full Text] [Related]
36. Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater.
Kim HS; Lee SH; Won KY; Kim GY; Park YK; Kim YW
Virchows Arch; 2012 Jan; 460(1):61-8. PubMed ID: 22102065
[TBL] [Abstract][Full Text] [Related]
37. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
38. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A
Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982
[TBL] [Abstract][Full Text] [Related]
39. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
40. Ampullary adenocarcinoma - differentiation matters.
Schirmacher P; Büchler MW
BMC Cancer; 2008 Sep; 8():251. PubMed ID: 18761739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
